Leuprorelin Acetate CAS 74381-53-6: Uses, Dosage, Side Effects & More

Leuprorelin acetate, with CAS number 74381-53-6, is a potent medication used to treat hormone-responsive cancers such as prostate cancer, breast cancer, and certain gynecological disorders. It belongs to the class of gonadotropin-releasing hormone (GnRH) agonists and works by decreasing the production of certain hormones in the body, Demei Pharmaceutical Technology Co., Ltd. specializes in the development and production of high-quality Leuprorelin acetate. Our company is dedicated to providing pharmaceutical products that meet international standards and regulatory requirements. With state-of-the-art facilities and a team of experienced professionals, we ensure that our Leuprorelin acetate is manufactured with the highest level of quality and purity, Our Leuprorelin acetate is available in various forms such as injections and implants, providing flexibility and convenience for healthcare providers and patients. With our commitment to excellence and innovation, we aim to contribute to the improvement of patient outcomes and the advancement of cancer treatment. Partner with Demei Pharmaceutical Technology Co., Ltd. for reliable and effective Leuprorelin acetate products